trial · primary record
Ivermectin
Anatomic Stage IV Breast Cancer AJCC v8
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 34 |
| Primary completion | 2026-10 |
| Primary endpoint | Incidence of adverse events |
| Registry ID | NCT05318469 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:46.994Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05318469
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.